T. Rowe Price Health Care ETF (NASDAQ:TMED) Shares Up 1.7% – What’s Next?

Shares of T. Rowe Price Health Care ETF (NASDAQ:TMED) traded up 1.7% during trading on Friday . The company traded as high as $29.95 and last traded at $29.94. 601 shares were traded during mid-day trading, a decline of 74% from the average session volume of 2,336 shares. The stock had previously closed at $29.44.

T. Rowe Price Health Care ETF Stock Performance

The company has a market capitalization of $14.97 million, a price-to-earnings ratio of -22.01 and a beta of 1.62. The company has a fifty day moving average of $29.13.

Hedge Funds Weigh In On T. Rowe Price Health Care ETF

Several institutional investors have recently modified their holdings of the company. Essex Financial Services Inc. bought a new stake in T. Rowe Price Health Care ETF in the 3rd quarter valued at about $243,000. Citadel Advisors LLC increased its stake in shares of T. Rowe Price Health Care ETF by 210.6% in the third quarter. Citadel Advisors LLC now owns 29,774 shares of the company’s stock valued at $794,000 after purchasing an additional 20,189 shares during the period. Finally, Flow Traders U.S. LLC bought a new stake in shares of T. Rowe Price Health Care ETF during the third quarter valued at approximately $1,259,000.

About T. Rowe Price Health Care ETF

The T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The fund’s investment portfolio concentrates primarily on health care equity. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.